Old Web
English
Sign In
Acemap
>
authorDetail
>
Inga Tschoepe
Inga Tschoepe
Pathology
Afatinib
Medicine
Vinorelbine
Pharmacology
4
Papers
24
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Phase I open-label study of afatinib plus vinorelbine in patients with solid tumours overexpressing EGFR and/or HER2
2018
British Journal of Cancer
Rastislav Bahleda
Andrea Varga
Yann Berge
Jean-Charles Soria
David Schnell
Inga Tschoepe
Martina Uttenreuther-Fischer
Jean-Pierre Delord
Show All
Source
Cite
Save
Citations (5)
Phase I safety and tolerability of once daily oral afatinib (A) in combination with docetaxel (D) in patients (pts) with relapsed or refractory advanced solid tumors.
2017
Journal of Clinical Oncology
Hélène Senellart
Jaafar Bennouna
Nicolas Isambert
Helene De-Montserrat
Patrick J. Squiban
Inga Tschoepe
Jean-Pierre Delord
Show All
Source
Cite
Save
Citations (2)
Phase I trial to assess the safety and pharmacokinetics of afatinib and weekly vinorelbine in patients with advanced solid tumors.
2017
Journal of Clinical Oncology
Antoine Hollebecque
Rastislav Bahleda
Yann Berge
Christophe Massard
Martina Uttenreuther-Fischer
Helene De-Montserrat
Inga Tschoepe
Jean-Charles Soria
Jean-Pierre Delord
Show All
Source
Cite
Save
Citations (6)
Phase I trial assessing safety and pharmacokinetics of afatinib (BIBW 2992) with intravenous weekly vinorelbine in advanced solid tumors.
2011
Journal of Clinical Oncology
R. Bahleda
J.C. Soria
Yann Berge
Christophe Massard
Sven Wind
Martina Uttenreuther-Fischer
Frank Fleischer
Helene De-Montserrat
Flavio Solca
Inga Tschoepe
Jean-Pierre Delord
Show All
Source
Cite
Save
Citations (11)
1